Inflammation  >>  Gazyva (obinutuzumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gazyva (obinutuzumab) / Roche, Biogen
NCT02174172: A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors

Checkmark For P1 trial for locally advanced or metastatic solid tumors
Aug 2014 - Aug 2014: For P1 trial for locally advanced or metastatic solid tumors
Completed
1
158
Europe, US
Atezolizumab, Tecentriq, RO5541267, MPDL3280A, Bevacizumab, Avastin®, Interferon alfa-2b, Ipilimumab, Obinutuzumab, PEG-interferon alfa-2a, Pegasys®
Hoffmann-La Roche
Solid Cancers
11/19
11/19

Download Options